Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

Amalia Colalillo, Eric Hachulla, Chiara Pellicano, Vanessa Smith, Christina Bergmann, Gabriela Riemekasten, Elisabetta Zanatta, Jörg Henes, David Launay, Antonella Marcoccia, Ana Maria Gheorghiu, Marie Elise Truchetet, Florenzo Iannone, Carmen Pilar Simeón Aznar, Susana Oliveira, Madelon Vonk, Francesco Del Galdo, Edoardo Rosato*, Oliver Distler, Mike BeckerMelissa De Decker, Danilo Alunni Fegatelli, Elise Siegert, Ivan Castellví, Alberto Cauli, Kamal Solanki, Lorenzo Dagna, Mickaël Martin, Gianluca Moroncini, Hadi Poormoghim, Masataka Kuwana, Patricia E. Carreira, Paolo Airò, Julia Spierings, Yoshiya Tanaka, Enrico Selvi, Tomas Soukup

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background: The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a “gray zone” of unclear clinical significance. Research Question: What is the diagnostic performance of the main parameters used for PH screening in detecting patients with systemic sclerosis (SSc) with an mPAP of 21 to 24 mm Hg at RHC? Study Design and Methods: Patients with SSc from the European Scleroderma Trials and Research (EUSTAR) database with available tricuspid annular plane systolic excursion (TAPSE), systolic PAP (sPAP), and mPAP data were included. Patients with mPAP 21 to 24 mm Hg and patients with mPAP ≤ 20 mm Hg were considered for the analysis. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated. Results: TAPSE/sPAP was lower in the group of patients with SSc with mPAP 21 to 24 mm Hg than in the non-PH group (0.58 [0.46-0.72] vs 0.69 [0.57-0.81] mm/mm Hg, respectively; P < .01). No difference was found in other parameters between the two groups. Diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value had the highest sensitivity (88.9%) and NPV (80%), but the lowest specificity (18.2%) and PPV (30.8%) in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity (78.9%), PPV (50%), and accuracy (68.1%); its NPV was 75.4%, and its sensitivity was 45.1%. Interpretation: In this study, diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value was the parameter with the highest sensitivity and NPV in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity, PPV, and accuracy and, therefore, can be a useful additional parameter to decrease the number of unnecessary RHCs.

OriginalspracheEnglisch
ZeitschriftChest
Jahrgang166
Ausgabenummer4
Seiten (von - bis)837-844
Seitenumfang8
ISSN0012-3692
DOIs
PublikationsstatusVeröffentlicht - 10.2024

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

DFG-Fachsystematik

  • 2.22-18 Rheumatologie
  • 2.21-05 Immunologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren